Clinical Trial Update: 6 Weeks Right-Amygdala TIS for Depression [NA]

View source ↗

Summary

A clinical trial update indicates a study of right-amygdala TIS therapy for major depressive disorder is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Ruijin Hospital | Conditions: Major Depressive Disorder (MDD) | NA | Status: ENROLLING_BY_INVITATION